tiprankstipranks
Circassia Pharmaceuticals PLC (GB:NIOX)
LSE:NIOX
UK Market
NIOX
Circassia Pharmaceuticals
RESEARCH TOOLSreports
Want to see GB:NIOX full AI Analyst Report?

Circassia Pharmaceuticals (NIOX) Income Statement

14 Followers

Circassia Pharmaceuticals Income Statement

Last quarter (Q4 2025), Circassia Pharmaceuticals's total revenue was £23.50M, an increase of 30.56% from the same quarter last year. In Q4, Circassia Pharmaceuticals's net income was £1.10M. See Circassia Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
£ 48.70M£ 41.80M£ 36.80M£ 31.30M£ 27.90M
Gross Profit
£ 29.60M£ 30.20M£ 26.50M£ 22.20M£ 19.00M
Operating Expenses
£ 18.90M£ 22.50M£ 21.90M£ 20.40M£ 23.30M
Depreciation and Amortization
£ 0.00£ 4.20M£ 4.40M£ 4.60M£ 4.90M
EBITDA
£ 10.70M£ 12.20M£ 8.60M£ 15.20M£ 3.10M
Operating Income
£ 10.70M£ 7.70M£ 4.60M£ 1.80M£ -4.30M
Other Income/Expenses
£ 500.00K£ 100.00K£ -500.00K£ 8.70M£ 2.20M
Pretax Income
£ 11.20M£ 7.80M£ 4.10M£ 10.50M£ -2.10M
Net Income
£ 7.00M£ 3.70M£ 10.70M£ 16.10M£ 3.60M
Per Share Metrics
Basic EPS
£ 0.02£ 0.01£ 0.03£ 0.04£ 0.01
Diluted EPS
£ 0.02£ 0.01£ 0.02£ 0.04£ 0.01
Weighted Average Shares Outstanding
 414.17M 418.21M 420.20M 419.20M 412.61M
Weighted Average Shares Outstanding (Diluted)
 426.22M 448.21M 449.28M 443.00M 435.83M
Currency in GBP

Circassia Pharmaceuticals Earnings and Revenue History